156 related articles for article (PubMed ID: 28855448)
1. Caffeine Has a Synergistic Anticancer Effect with Cisplatin via Inhibiting Fanconi Anemia Group D2 Protein Monoubiquitination in Hepatocellular Carcinoma Cells.
Oda Y; Hidaka M; Suzuki A
Biol Pharm Bull; 2017 Nov; 40(11):2005-2009. PubMed ID: 28855448
[TBL] [Abstract][Full Text] [Related]
2. High-risk human papillomavirus oncogenes disrupt the Fanconi anemia DNA repair pathway by impairing localization and de-ubiquitination of FancD2.
Khanal S; Galloway DA
PLoS Pathog; 2019 Feb; 15(2):e1007442. PubMed ID: 30818369
[TBL] [Abstract][Full Text] [Related]
3. Curcumin reverses cisplatin resistance in cisplatin-resistant lung caner cells by inhibiting FA/BRCA pathway.
Chen P; Li J; Jiang HG; Lan T; Chen YC
Tumour Biol; 2015 May; 36(5):3591-9. PubMed ID: 25542235
[TBL] [Abstract][Full Text] [Related]
4. Proteasome function is required for DNA damage response and fanconi anemia pathway activation.
Jacquemont C; Taniguchi T
Cancer Res; 2007 Aug; 67(15):7395-405. PubMed ID: 17671210
[TBL] [Abstract][Full Text] [Related]
5. A novel role for non-ubiquitinated FANCD2 in response to hydroxyurea-induced DNA damage.
Chen X; Bosques L; Sung P; Kupfer GM
Oncogene; 2016 Jan; 35(1):22-34. PubMed ID: 25893307
[TBL] [Abstract][Full Text] [Related]
6. Nuclear α Spectrin Differentially Affects Monoubiquitinated Versus Non-Ubiquitinated FANCD2 Function After DNA Interstrand Cross-Link Damage.
Zhang P; Sridharan D; Lambert MW
J Cell Biochem; 2016 Mar; 117(3):671-83. PubMed ID: 26297932
[TBL] [Abstract][Full Text] [Related]
7. Loss of CHK1 function impedes DNA damage-induced FANCD2 monoubiquitination but normalizes the abnormal G2 arrest in Fanconi anemia.
Guervilly JH; Macé-Aimé G; Rosselli F
Hum Mol Genet; 2008 Mar; 17(5):679-89. PubMed ID: 18029388
[TBL] [Abstract][Full Text] [Related]
8. Ubiquitination-Linked Phosphorylation of the FANCI S/TQ Cluster Contributes to Activation of the Fanconi Anemia I/D2 Complex.
Cheung RS; Castella M; Abeyta A; Gafken PR; Tucker N; Taniguchi T
Cell Rep; 2017 Jun; 19(12):2432-2440. PubMed ID: 28636932
[TBL] [Abstract][Full Text] [Related]
9. Activation of the Fanconi anemia/BRCA pathway and recombination repair in the cellular response to solar ultraviolet light.
Dunn J; Potter M; Rees A; Rünger TM
Cancer Res; 2006 Dec; 66(23):11140-7. PubMed ID: 17145857
[TBL] [Abstract][Full Text] [Related]
10. Non-specific chemical inhibition of the Fanconi anemia pathway sensitizes cancer cells to cisplatin.
Jacquemont C; Simon JA; D'Andrea AD; Taniguchi T
Mol Cancer; 2012 Apr; 11():26. PubMed ID: 22537224
[TBL] [Abstract][Full Text] [Related]
11. The RPA inhibitor HAMNO sensitizes Fanconi anemia pathway-deficient cells.
Jang SW; Kim JM
Cell Cycle; 2022 Jul; 21(14):1468-1478. PubMed ID: 35506981
[TBL] [Abstract][Full Text] [Related]
12. Celastrol induces proteasomal degradation of FANCD2 to sensitize lung cancer cells to DNA crosslinking agents.
Wang GZ; Liu YQ; Cheng X; Zhou GB
Cancer Sci; 2015 Jul; 106(7):902-8. PubMed ID: 25891850
[TBL] [Abstract][Full Text] [Related]
13. A novel cell-free screen identifies a potent inhibitor of the Fanconi anemia pathway.
Landais I; Sobeck A; Stone S; LaChapelle A; Hoatlin ME
Int J Cancer; 2009 Feb; 124(4):783-92. PubMed ID: 19048618
[TBL] [Abstract][Full Text] [Related]
14. CRL4 ubiquitin ligase stimulates Fanconi anemia pathway-induced single-stranded DNA-RPA signaling.
Codilupi T; Taube D; Naegeli H
BMC Cancer; 2019 Nov; 19(1):1042. PubMed ID: 31690264
[TBL] [Abstract][Full Text] [Related]
15. Fanconi anemia protein FANCD2 promotes immunoglobulin gene conversion and DNA repair through a mechanism related to homologous recombination.
Yamamoto K; Hirano S; Ishiai M; Morishima K; Kitao H; Namikoshi K; Kimura M; Matsushita N; Arakawa H; Buerstedde JM; Komatsu K; Thompson LH; Takata M
Mol Cell Biol; 2005 Jan; 25(1):34-43. PubMed ID: 15601828
[TBL] [Abstract][Full Text] [Related]
16. Conserved function of Drosophila Fancd2 monoubiquitination in response to double-strand DNA breaks.
Clay DE; Jezuit EA; Montague RA; Fox DT
G3 (Bethesda); 2022 Jul; 12(8):. PubMed ID: 35595243
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of Ubiquitination and Deubiquitination in the Fanconi Anemia Pathway.
van Twest S; Murphy VJ; Hodson C; Tan W; Swuec P; O'Rourke JJ; Heierhorst J; Crismani W; Deans AJ
Mol Cell; 2017 Jan; 65(2):247-259. PubMed ID: 27986371
[TBL] [Abstract][Full Text] [Related]
18. S-phase-specific interaction of the Fanconi anemia protein, FANCD2, with BRCA1 and RAD51.
Taniguchi T; Garcia-Higuera I; Andreassen PR; Gregory RC; Grompe M; D'Andrea AD
Blood; 2002 Oct; 100(7):2414-20. PubMed ID: 12239151
[TBL] [Abstract][Full Text] [Related]
19. UBE2W interacts with FANCL and regulates the monoubiquitination of Fanconi anemia protein FANCD2.
Zhang Y; Zhou X; Zhao L; Li C; Zhu H; Xu L; Shan L; Liao X; Guo Z; Huang P
Mol Cells; 2011 Feb; 31(2):113-22. PubMed ID: 21229326
[TBL] [Abstract][Full Text] [Related]
20. Involvement of Fanconi anemia genes FANCD2 and FANCF in the molecular basis of drug resistance in leukemia.
Yao C; Du W; Chen H; Xiao S; Huang L; Chen FP
Mol Med Rep; 2015 Jun; 11(6):4605-10. PubMed ID: 25647473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]